{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:11:55Z","timestamp":1791439915391,"version":"4.3.3"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000849","name":"National Centre for the Replacement, Refinement and Reduction of Animals in Research","doi-asserted-by":"publisher","award":["NC\/NAM0019\/1"],"award-info":[{"award-number":["NC\/NAM0019\/1"]}],"id":[{"id":"10.13039\/501100000849","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["UKRI076"],"award-info":[{"award-number":["UKRI076"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leicester Institute for Advanced Studies","id":[{"id":"https:\/\/ror.org\/01mjdf856","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"abstract":"<jats:p>\n                    Lack of antibody validation by researchers frequently misdirects biomedical research, yet the ethical consequences\u2014particularly avoidable use of animal and human biological materials\u2014remain unquantified. Using focus groups (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200912), surveys (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009107), and systematic analysis of 785 publications, we examined how researchers select and validate antibodies, and quantified the downstream ethical costs. Antibody selection is substantially influenced by social factors such as previous laboratory use and peer recommendations, while systematic evaluation of performance characteristics remains limited. From a dataset of 614 antibodies subjected to rigorous characterisation using knockout controls, 97 (15.8%) failed across all tested applications; we systematically searched for publications linked to these antibodies. Within the 760 publications (those where validation status could be confirmed), only 120 (15.8%) presented any validation evidence\u2014despite 72.0% of surveyed researchers reporting having used at least one recommended validation method. The remaining 640 papers reported a minimum of 8,064 animal samples and 4,424 human tissue samples used with antibodies of demonstrated poor performance and without evidence of fitness for the specific experimental purpose; we describe these as samples at risk of waste. Reserving the term waste for samples used with reagents since withdrawn from sale, and therefore irreproducible, conservative extrapolation gives lower-bound, order-of-magnitude estimates of millions of animal and human tissue samples consumed globally. Researchers identified time, cost, and lack of supervisor support as primary barriers, whilst strongly supporting open data sharing, dedicated validation funding, and publisher requirements as solutions. These findings provide a first quantification of the ethical costs of inadequate antibody validation and highlight the need for coordinated stakeholder interventions to reduce avoidable biological sample waste in biomedical research.\n                  <\/jats:p>","DOI":"10.1371\/journal.pbio.3003984","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:23:04Z","timestamp":1791307384000},"page":"e3003984","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Inadequate antibody validation places substantial numbers of animal and human tissue samples at risk of waste"],"prefix":"10.1371","volume":"24","author":[{"given":"Michael","family":"Biddle","sequence":"first","affiliation":[{"name":"School of Medical Sciences, College of Life Sciences, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemma","family":"Cooper","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, College of Life Sciences, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Blades","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, College of Life Sciences, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Ruddy","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, College of Life Sciences, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8748-9897","authenticated-orcid":true,"given":"Eva M.","family":"Krockow","sequence":"additional","affiliation":[{"name":"School of Psychology and Vision Sciences, College of Life Sciences, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9739-9593","authenticated-orcid":true,"given":"Harvinder","family":"Virk","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, College of Life Sciences, University of Leicester","place":["Leicester, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"pbio.3003984.ref001","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91645.2","article-title":"Scaling of an antibody validation procedure enables quantification of antibody performance in major research applications","volume":"12","author":"R Ayoubi","year":"2023","journal-title":"Elife"},{"issue":"5","key":"pbio.3003984.ref002","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood-2005-10-4066","article-title":"Anti-Epo receptor antibodies do not predict Epo receptor expression","volume":"107","author":"S Elliott","year":"2006","journal-title":"Blood"},{"issue":"10","key":"pbio.3003984.ref003","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1074\/mcp.R800013-MCP200","article-title":"A genecentric Human Protein Atlas for expression profiles based on antibodies","volume":"7","author":"L Berglund","year":"2008","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"pbio.3003984.ref004","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/j.1365-2559.2011.04034.x","article-title":"Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies","volume":"59","author":"A-S Schrohl","year":"2011","journal-title":"Histopathology"},{"issue":"3","key":"pbio.3003984.ref005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2144\/000114074","article-title":"Commercial Cdk1 antibodies recognize the centrosomal protein Cep152","volume":"55","author":"G Lukinavi\u010dius","year":"2013","journal-title":"Biotechniques"},{"issue":"7552","key":"pbio.3003984.ref006","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/521274a","article-title":"Reproducibility crisis: blame it on the antibodies","volume":"521","author":"M Baker","year":"2015","journal-title":"Nature"},{"key":"pbio.3003984.ref007","doi-asserted-by":"crossref","first-page":"15840","DOI":"10.1038\/ncomms15840","article-title":"Insufficient antibody validation challenges oestrogen receptor beta research","volume":"8","author":"S Andersson","year":"2017","journal-title":"Nat Commun"},{"key":"pbio.3003984.ref008","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48363","article-title":"Implementation of an antibody characterization procedure and application to the major ALS\/FTD disease gene C9ORF72","volume":"8","author":"C Laflamme","year":"2019","journal-title":"Elife"},{"issue":"1","key":"pbio.3003984.ref009","doi-asserted-by":"crossref","first-page":"18500","DOI":"10.1038\/s41598-019-55133-7","article-title":"Validation of antibodies for the specific detection of human TRPA1","volume":"9","author":"HS Virk","year":"2019","journal-title":"Sci Rep"},{"issue":"8037","key":"pbio.3003984.ref010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/d41586-024-03590-0","article-title":"The antibodies don\u2019t work! The race to rid labs of molecules that ruin experiments","volume":"635","author":"D Kwon","year":"2024","journal-title":"Nature"},{"issue":"6","key":"pbio.3003984.ref011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002165","article-title":"The economics of reproducibility in preclinical research","volume":"13","author":"LP Freedman","year":"2015","journal-title":"PLoS Biol"},{"key":"pbio.3003984.ref012","article-title":"Antibody characterization is critical to enhance reproducibility in biomedical research","volume":"13","author":"RA Kahn","year":"2024","journal-title":"Elife"},{"issue":"7974","key":"pbio.3003984.ref013","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/d41586-023-02566-w","article-title":"Heed a decade of calls for antibody validation","volume":"620","author":"RA Kahn","year":"2023","journal-title":"Nature"},{"issue":"1","key":"pbio.3003984.ref014","doi-asserted-by":"crossref","first-page":"2323706","DOI":"10.1080\/19420862.2024.2323706","article-title":"Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge","volume":"16","author":"M Biddle","year":"2024","journal-title":"MAbs"},{"issue":"1","key":"pbio.3003984.ref015","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2144\/000114431","article-title":"[Letter to the Editor] The need for improved education and training in research antibody usage and validation practices","volume":"61","author":"LP Freedman","year":"2016","journal-title":"Biotechniques"},{"key":"pbio.3003984.ref016","volume-title":"EURL ECVAM recommendation on non-animal-derived antibodies. EUR 30185 EN","author":"JF Viegas Barroso","year":"2020"},{"issue":"6","key":"pbio.3003984.ref017","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41596-024-01095-8","article-title":"A consensus platform for antibody characterization","volume":"20","author":"R Ayoubi","year":"2025","journal-title":"Nat Protoc"},{"issue":"10","key":"pbio.3003984.ref018","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nmeth.3995","article-title":"A proposal for validation of antibodies","volume":"13","author":"M Uhlen","year":"2016","journal-title":"Nat Methods"},{"key":"pbio.3003984.ref019","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"S Michie","year":"2011","journal-title":"Implement Sci"},{"key":"pbio.3003984.ref020","article-title":"Actionable solutions to address antibody validation failures","author":"K Blades","year":"2026","journal-title":"PLoS Biol"},{"issue":"13","key":"pbio.3003984.ref021","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/1049732315617444","article-title":"Sample size in qualitative interview studies: guided by information power","volume":"26","author":"K Malterud","year":"2016","journal-title":"Qual Health Res"},{"key":"pbio.3003984.ref022","author":"R Ayoubi","year":"2026"},{"key":"pbio.3003984.ref023","doi-asserted-by":"crossref","DOI":"10.4135\/9781036232078.n9","volume-title":"Thematic analysis: a practical guide","author":"V Braun","year":"2021"},{"key":"pbio.3003984.ref024","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.12688\/f1000research.141719.1","article-title":"YCharOS open antibody characterisation data: lessons learned and progress made","volume":"12","author":"MS Biddle","year":"2023","journal-title":"F1000Res"},{"key":"pbio.3003984.ref025","unstructured":"CiteAb. Leading research antibodies: top 100 cited products, 2024 update. CiteAb Blog. 2024 [Cited 2026 February 19]. Available from https:\/\/blog.citeab.com\/most-cited-research-antibodies-2023\/"},{"key":"pbio.3003984.ref026","unstructured":"Labome. Abcam antibodies. 2023 [Cited 2026 February 19]. Available from https:\/\/www.labome.com\/method\/Abcam-Antibodies.html"},{"key":"pbio.3003984.ref027","unstructured":"Market Growth Reports. Research antibodies and reagents market size, share and forecasts. 2025 [Cited 2026 Feb 19]. Available from https:\/\/www.marketgrowthreports.com\/market-reports\/research-antibodies-and-reagents-market-116424"}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3003984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:23:11Z","timestamp":1791307391000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3003984"}},"subtitle":[],"editor":[{"given":"Eunjoon","family":"Kim","sequence":"first","affiliation":[{"name":"Institute for Basic Science","place":["KOREA, REPUBLIC OF"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3003984","relation":{},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}